Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS

Completed · Not applicable

Conditions studied: Acquired Immunodeficiency Syndrome, HIV/AIDS, Alcohol Drinking

In brief

While advances in medication have led to greatly improved outcomes for people living with HIV/AIDS, less than one-third of all people living with the disease are adherent enough to their medication to achieve viral suppression. Alcohol consumption has been shown to have a significant effect on HIV medication adherence, so the proposed research will aim to reduce alcohol use among people living with HIV/AIDS through a technology-driven intervention. This eight-session intervention will be delivered using a combination of videoconferencing, smart phones, and Bluetooth-enabled breathalyzers for monitoring of alcohol consumption, with an overall goal of reducing alcohol use, mitigating adherence issues, and achieving optimal prevention and treatment responses for people living with HIV/AIDS.

Key facts

Study ID

NCT03746600

Run by

Carolyn Lauckner

People needed

50

Starts

2020-05-23

Expected to finish

2023-06-07

Last updated by the study team

2024-08-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV-positive
• 18 years or older
• At-risk drinker
• Currently prescribed HIV medication
• Current patient at the study recruitment site(s)

You may not qualify if…

• Less than 18 years old
• Non-English Speaking

Where it is running

• Atlanta Veterans Health Care System — Decatur, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.